找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Drug Adherence in Hypertension and Cardiovascular Protection; Michel Burnier Book 2018 Springer International Publishing AG, part of Sprin

[复制链接]
查看: 48110|回复: 54
发表于 2025-3-21 19:25:01 | 显示全部楼层 |阅读模式
书目名称Drug Adherence in Hypertension and Cardiovascular Protection
编辑Michel Burnier
视频video
概述Illustrates how to apply new technologies in assessing and monitoring drug adherence..Sheds light on the importance of adherence monitoring in clinical trials..Highlights the role of a multidisciplina
丛书名称Updates in Hypertension and Cardiovascular Protection
图书封面Titlebook: Drug Adherence in Hypertension and Cardiovascular Protection;  Michel Burnier Book 2018 Springer International Publishing AG, part of Sprin
描述.This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient‘s adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of sev
出版日期Book 2018
关键词drug adherence monitoring; resistant hypertension; clinical trials; healthcare network; cost-effectivene
版次1
doihttps://doi.org/10.1007/978-3-319-76593-8
isbn_softcover978-3-030-09528-4
isbn_ebook978-3-319-76593-8Series ISSN 2366-4606 Series E-ISSN 2366-4614
issn_series 2366-4606
copyrightSpringer International Publishing AG, part of Springer Nature 2018
The information of publication is updating

书目名称Drug Adherence in Hypertension and Cardiovascular Protection影响因子(影响力)




书目名称Drug Adherence in Hypertension and Cardiovascular Protection影响因子(影响力)学科排名




书目名称Drug Adherence in Hypertension and Cardiovascular Protection网络公开度




书目名称Drug Adherence in Hypertension and Cardiovascular Protection网络公开度学科排名




书目名称Drug Adherence in Hypertension and Cardiovascular Protection被引频次




书目名称Drug Adherence in Hypertension and Cardiovascular Protection被引频次学科排名




书目名称Drug Adherence in Hypertension and Cardiovascular Protection年度引用




书目名称Drug Adherence in Hypertension and Cardiovascular Protection年度引用学科排名




书目名称Drug Adherence in Hypertension and Cardiovascular Protection读者反馈




书目名称Drug Adherence in Hypertension and Cardiovascular Protection读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:53:16 | 显示全部楼层
https://doi.org/10.1007/978-3-662-24745-7ons and a maximum of 2 hours of post-DOT-HTN observation. Three reports had longer observation time, two of them with medication administration intervals, and blood pressure measurement intervals. Two were case reports, describing severe post-DOT-HTN adverse reactions, contributing with important sa
发表于 2025-3-22 01:12:59 | 显示全部楼层
https://doi.org/10.1007/978-3-662-24745-7 cannot be assessed this way. These uncertainties reduce the value of biochemical monitoring. Biochemical monitoring of adherence should be preceded by informed consent unless it is performed for research purposes at the group level and with necessary ethical approval. The risk/benefit ratio of bioc
发表于 2025-3-22 06:30:25 | 显示全部楼层
https://doi.org/10.1007/978-3-662-24745-7hers in lower tolerability. We discuss how this heterogeneity of treatment effect may lead to differential impacts of antihypertensive drugs on medication adherence among individual patients. We conclude by suggesting approaches to preventing adverse effects of antihypertensive drugs on medication a
发表于 2025-3-22 10:46:37 | 显示全部楼层
发表于 2025-3-22 15:32:48 | 显示全部楼层
https://doi.org/10.1007/978-3-662-24745-7e and avoid unnecessary treatment intensification. Given the expanding population with uncontrolled and resistant hypertension and emerging cost–benefits of adherence, addressing non-adherence to prescribed antihypertensive therapy is a top priority.
发表于 2025-3-22 18:36:15 | 显示全部楼层
Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the Lombadherence to statin treatment; and (4) there was a significant positive relationship between reduced adherence to treatment and increased risk of hospitalization for coronary disease, cerebrovascular disease, and heart failure. This was the case in younger and older patients, including those >85 year
发表于 2025-3-22 21:18:19 | 显示全部楼层
Directly Observed Therapy in Hypertension (DOT-HTN)ons and a maximum of 2 hours of post-DOT-HTN observation. Three reports had longer observation time, two of them with medication administration intervals, and blood pressure measurement intervals. Two were case reports, describing severe post-DOT-HTN adverse reactions, contributing with important sa
发表于 2025-3-23 04:03:36 | 显示全部楼层
发表于 2025-3-23 05:33:01 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-29 22:50
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表